PPARs: a potential target for a disease-modifying strategy in stroke.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Drug Targets

• Publication date

  2013-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1389450111314070005PMID 23514380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Examining the safety of PPAR agonists – current trends and future prospects

  2013cited by this paper
• Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention

  2013cited by this paper
• Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusion.

  2012cited by this paper
• Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.

  2012cited by this paper
• Activation of peroxisome proliferator‐activated receptor‐δ attenuates glutamate‐induced neurotoxicity in HT22 mouse hippocampal cells

  2012cited by this paper
• Microvascular protection is essential for successful neuroprotection in stroke

  2012cited by this paper
• Thiazolidinedione safety

  2012cited by this paper
• Angiogenesis: A Harmonized Target for Recovery After Stroke

  2012cited by this paper
• Reactive oxygen species and ischemic cerebrovascular disease.

  2012cited by this paper
• Benefits of prestroke use of angiotensin type 1 receptor blockers on ischemic stroke severity.

  2012cited by this paper
• Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology

  2012cited by this paper
• Pathophysiologic Cascades in Ischemic Stroke

  2012cited by this paper
• Statins for acute ischemic stroke.

  2011cited by this paper
• Vascular Protection Following Cerebral Ischemia and Reperfusion.

  2011cited by this paper
• The immunology of stroke: from mechanisms to translation

  2011cited by this paper
• The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease

  2011cited by this paper
• Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial.

  2011cited by this paper
• Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

  2011cited by this paper
• Cellular Mechanisms of Neurovascular Damage and Repair After Stroke

  2011cited by this paper
• The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.

  2011cited by this paper
• Vascular PPAR&dgr; Protects Against Stroke-Induced Brain Injury

  2011cited by this paper
• Peroxisome proliferator‐activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo

  2011cited by this paper
• GW1929: a nonthiazolidinedione PPARγ agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation.

  2011cited by this paper
• Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.

  2011cited by this paper
• Pleiotropic effects of ARB on dyslipidemia.

  2011cited by this paper
• Multifunctional actions of approved and candidate stroke drugs

  2011cited by this paper
• Neuroprotective efficacy of the peroxisome proliferator-activated receptor-γ ligand in chronic cerebral hypoperfusion.

  2011cited by this paper
• Fenofibrate Improves Cerebral Blood Flow after Middle Cerebral Artery Occlusion in Mice

  2010cited by this paper
• articlePretreatment with statins improves early outcome in patients with first-ever ischaemic stroke : a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia ?

  2010cited by this paper
• Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.

  2010cited by this paper
• The neurovascular unit in the setting of stroke

  2010cited by this paper
• Statin and fibrate combination therapy may be an appropriate therapeutic approach to reduce the global cardiovascular risk in patients with atherogenic or combined dyslipidemia

  2010cited by this paper
• Leukocyte Recruitment and Ischemic Brain Injury

  2010cited by this paper
• Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction

  2010cited by this paper
• Peroxisome Proliferator-Activated Receptor δ Regulation of miR-15a in Ischemia-Induced Cerebral Vascular Endothelial Injury

  2010cited by this paper
• Angiogenesis, neurogenesis and brain recovery of function following injury.

  2010cited by this paper
• The neurovascular unit in the setting of stroke

  2010cited by this paper
• Peroxisome-proliferator-activated receptors γ and peroxisome-proliferator-activated receptors β/δ and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain

  2010cited by this paper
• Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

  2010cited by this paper
• Brain inflammation and adult neurogenesis: the dual role of microglia.

  2009cited by this paper
• Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release

  2009cited by this paper
• Rosiglitazone Alone Or in Combination with Tissue Plasminogen Activator Improves Ischemic Brain Injury in an Embolic Model in Rats

  2009cited by this paper
• Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.

  2009cited by this paper
• Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice.

  2009cited by this paper
• Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

  2009cited by this paper
• Pre-Stroke Use of Antihypertensives, Antiplatelets, or Statins and Early Ischemic Stroke Outcomes

  2009cited by this paper
• Relationship of Neurovascular Elements to Neuron Injury during Ischemia

  2009cited by this paper
• Ligand-Activated Peroxisome Proliferator–Activated Receptor-γ Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3&egr; Upregulation

  2009cited by this paper
• Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.

  2009cited by this paper
• Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

  2009cited by this paper
• Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators

  2009cited by this paper
• Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.

  2009cited by this paper
• Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection.

  2009cited by this paper
• Lipid-Lowering Drugs in Ischemic Stroke Prevention and Their Influence on Acute Stroke Outcome

  2009cited by this paper
• Peroxisome Proliferator-Activated Receptor-α Activation Protects Brain Capillary Endothelial Cells from Oxygen-Glucose Deprivation-Induced Hyperpermeability in the Blood-Brain Barrier

  2009cited by this paper
• Cerebral Protection, Brain Repair, Plasticity and Cell Therapy in Ischemic Stroke

  2009cited by this paper
• The development of stroke therapeutics: promising mechanisms and translational challenges.

  2009cited by this paper
• Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia

  2009cited by this paper
• Oxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke

  2009cited by this paper
• Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.

  2009cited by this paper
• Emerging Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Regulation of Neural Stem Cells Proliferation and Differentiation

  2008cited by this paper
• Stroke.

  2008cited by this paper
• PPARγ agonist pioglitazone rescues neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Peroxisome proliferator‐activated receptorsγ (PPARγ) differently modulate the interleukin‐6 expression in the peri‐infarct cortical tissue in the acute and delayed phases of cerebral ischaemia

  2008cited by this paper
• Neuroprotection for ischemic stroke: past, present and future.

  2008cited by this paper
• Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.

  2007cited by this paper
• High-Resolution In Vivo Imaging of the Neurovascular Unit during Spreading Depression

  2007cited by this paper
• PPARs Expression in Adult Mouse Neural Stem Cells: Modulation of PPARs during Astroglial Differentiaton of NSC

  2007cited by this paper
• Neurogliovascular unit after cerebral ischemia: is the vascular wall a pharmacological target.

  2007cited by this paper
• Repairing brain after stroke: a review on post-ischemic neurogenesis.

  2007cited by this paper
• Update on PPAR agonists: The clinical significance of FIELD and PROACTIVE

  2007cited by this paper
• MRI monitoring of focal cerebral ischemia in peroxisome proliferator‐activated receptor (PPAR)‐deficient mice

  2007cited by this paper
• Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.

  2007cited by this paper
• Peroxisome Proliferator-activated Receptor γ Up-regulates the Bcl-2 Anti-apoptotic Protein in Neurons and Induces Mitochondrial Stabilization and Protection against Oxidative Stress and Apoptosis*

  2007cited by this paper
• Activation of PPAR&bgr;/&dgr; Induces Endothelial Cell Proliferation and Angiogenesis

  2007cited by this paper
• Stroke and Neurovascular Protection

  2006cited by this paper
• Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.

  2006cited by this paper
• Peroxisome proliferator-activated receptor agonist regulation of glial activation: Relevance to CNS inflammatory disorders

  2006cited by this paper
• Altered PPARgamma expression and activation after transient focal ischemia in rats.

  2006cited by this paper
• Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.

  2006cited by this paper
• Altered PPARγ expression and activation after transient focal ischemia in rats

  2006cited by this paper
• Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.

  2006cited by this paper
• Peroxisome proliferator-activated receptor-γ-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia

  2006cited by this paper
• Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.

  2006cited by this paper
• Stable Stroke Incidence Rates but Improved Case-Fatality in Dijon, France, From 1985 to 2004

  2006cited by this paper
• Stroke and neurovascular protection.

  2006cited by this paper
• Peroxisome proliferator‐activated receptor‐γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type‐2 diabetic rodents

  2006cited by this paper
• Increased Infarct Size and Lack of Hyperphagic Response after Focal Cerebral Ischemia in Peroxisome Proliferator-Activated Receptor β-Deficient Mice

  2006cited by this paper
• Peroxisome-proliferator-activated receptor-gamma (PPARγ) activation protects neurons from NMDA excitotoxicity

  2006cited by this paper
• Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

  2006cited by this paper
• ROSIGLITAZONE, A PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐γ LIGAND, REDUCES INFARCTION VOLUME AND NEUROLOGICAL DEFICITS IN AN EMBOLIC MODEL OF STROKE

  2006cited by this paper
• Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity

  2006cited by this paper
• Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms

  2006cited by this paper
• Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.

  2006cited by this paper
• Peroxisome proliferator-activated receptors and inflammation.

  2006cited by this paper
• Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.

  2005cited by this paper
• Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α

  2005cited by this paper
• Pioglitazone, a PPARγ agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats

  2005cited by this paper
• Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia

  2005cited by this paper

• Pharmacotherapeutic potential of soy isoflavones in neurological disorders

  2022cites this paper
• Rosiglitazone Protects Blood-Brain Barrier Integrity Following Ischemic Stroke by Reducing MMP-9 Expression Through a Caveolin-1-Dependent Pathway.

  2020cites this paper
• Brain–liver axis: a new pathway for cognitive disorders related to hepatic fibrosis

  2020cites this paper
• Neutrophils in tPA‐induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?

  2019cites this paper
• Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPARγ/NF-κB/IL-6 signaling pathway

  2019cites this paper
• Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPARγ.

  2019cites this paper
• FGF21 Protects the Blood–Brain Barrier by Upregulating PPARγ via FGFR1/β-klotho after Traumatic Brain Injury

  2018cites this paper
• Role of cortical microbleeds in cognitive impairment: In vivo behavioral and imaging characterization of a novel murine model

  2018cites this paper
• Genistein: mechanisms of action for a pleiotropic neuroprotective agent in stroke

  2017cites this paper
• Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders

  2017cites this paper
• Estimating The Variables Of The Nonlinear Dynamical Theory Of Acute Cell Injury

  2017cites this paper
• Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report

  2017cites this paper
• Sex differences in the immune response to experimental stroke: Implications for translational research

  2017cites this paper
• Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats.

  2016cites this paper
• Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.

  2016cites this paper
• Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke.

  2015cites this paper
• Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice.

  2015cites this paper
• Septin4_i1 Regulates Apoptosis in Hepatic Stellate Cells through Peroxisome Proliferator-Activated Receptor-γ/Akt/B-Cell Lymphoma 2 Pathway

  2015cites this paper
• PPAR-Alpha Agonist Used at the Acute Phase of Experimental Ischemic Stroke Reduces Occurrence of Thrombolysis-Induced Hemorrhage in Rats

  2015cites this paper
• Sex differences and the role of PPAR alpha in experimental stroke

  2015cites this paper
• Nuclear receptors in neurodegenerative diseases.

  2014cites this paper
• Effects of the PPAR-α Agonist Fenofibrate on Acute and Short-Term Consequences of Brain Ischemia

  2014cites this paper
• Neuroprotective Potential of Peroxisome Proliferator Activated Receptor-α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile

  2014cites this paper
• Recovery of brain biomarkers following peroxisome proliferator-activated receptor agonist neuroprotective treatment before ischemic stroke

  2014cites this paper
• Monitoring transcriptomic responses of SH-SY5Y cells to amyloid treatments

  2013cites this paper
• The first theme issue on PPARs for brain disorders.

  2013cites this paper